BioMérieux debuts unrated at tight spread
BioMérieux, the French medical diagnostics company, sold its first bond on Monday to a warm reception that showed just how tightly unrated companies can price.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: